Respiferon Project

Launched by HOSPICES CIVILS DE LYON · Aug 24, 2023

Keywords

ClinConnect Summary

The Respiferon Project is a clinical trial aimed at improving how we diagnose respiratory viral infections (RVIs), which are common illnesses that can affect both children and adults. Researchers are exploring a new method that looks at specific markers in the body's immune system to help identify the presence of viruses more quickly and accurately, rather than relying solely on traditional testing methods that can be slow and complicated. This study will focus on various RVIs during the winter months in a population in France.

To participate in the trial, individuals must have tested positive for a virus through a nasopharyngeal sample, which is a test that collects fluid from the back of the nose and throat. The researchers will need samples that have been stored since 2018. If you or a family member is interested in joining the trial, you can expect to provide a sample and receive information about the study, ensuring you understand what’s involved and that you agree to participate. This study is an important step toward developing faster and more effective ways to diagnose viral infections in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Positive nasopharyngeal samples for the detection of a virus, for which the replicative character has been established by the viral culture technique (500µL minimum required)
• • Samples kept at the CRB since 2018
• • Information to patients carried out and non-objection collected-
• Exclusion Criteria:
• • N/A